University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Mitchell Rosen, M.D.

Fertility specialist

Dr. Mitchell Rosen is a reproductive endocrinology and fertility expert at the UCSF Center for Reproductive Health. He also is director of the UCSF Fertillity Preservation Center, which helps patients with cancer preserve their ability to have children, despite aggressive cancer treatment.

Rosen earned a medical degree at Saint Louis University and completed residency training in obstetrics and gynecology at the University of Texas Medical Branch in Galveston, Texas. During medical and residency training, he was named the best resident twice and received the Ortho-McNeil Best Resident Teacher Award in 2002. Rosen completed fellowship training in reproductive endocrinology and infertility at UCSF. He was trained in the UCSF embryology laboratory to qualify as a high complexity lab director (HCLD). In addition to caring for patients, he is an assistant professor of medicine at UCSF and teaches medical students, residents and fellows.

Clinics

Center for Reproductive Health
2356 Sutter St., Seventh Floor
San Francisco, CA 94115
Phone: (415) 353-7475
Fax: (415) 353-7744

Hours: Monday to Friday
8 a.m. – 4:45 p.m.
Saturday and Sunday apts. available for patients undergoing treatment

Fertility Preservation Center
2356 Sutter St., Seventh Floor
San Francisco, CA 94115
Phone: (415) 353-9115
Fax: (415) 353-3064

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

More about Mitchell Rosen

Education

St. Louis University School of Medicine 1998

Residencies

University of Texas Medical Center, Obstetrics & Gynecology 2002

Fellowships

UCSF Medical Center 2003

Selected Research and Publications

  1. Cakmak H, Tran ND, Zamah AM, Cedars MI, Rosen MP. A novel "delayed start" protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders. Fertil Steril. 2014 May; 101(5):1308-14.
  2. Quinn MM, Letourneau JM, Rosen MP. Contraception after cancer treatment: describing methods, counseling, and unintended pregnancy risk. Contraception. 2014 May; 89(5):466-71.
  3. Bleil ME, Gregorich SE, McConnell D, Rosen MP, Cedars MI. Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease? Menopause. 2013 Nov; 20(11):1139-46.
  4. Bleil ME, Gregorich SE, Adler NE, Sternfeld B, Rosen MP, Cedars MI. Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women. Fertil Steril. 2014 Jan; 101(1):199-207.
  5. Letourneau J, Chan SW, Rosen MP. Accelerating ovarian age: cancer treatment in the premenopausal woman. Semin Reprod Med. 2013 Nov; 31(6):462-8.
  6. Cakmak H, Katz A, Cedars MI, Rosen MP. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril. 2013 Dec; 100(6):1673-80.
  7. Bleil ME, Bromberger JT, Latham MD, Adler NE, Pasch LA, Gregorich SE, Rosen MP, Cedars MI. Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause. Menopause. 2013 Jun; 20(6):631-9.
  8. Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril. 2013 May; 99(6):1476-84.
  9. Lin WT, Beattie M, Chen LM, Oktay K, Crawford SL, Gold EB, Cedars M, Rosen M. Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non-clinic-based sample of women in northern California. Cancer. 2013 May 1; 119(9):1652-9.
  10. Bleil ME, Adler NE, Pasch LA, Sternfeld B, Gregorich SE, Rosen MP, Cedars MI. Depressive symptomatology, psychological stress, and ovarian reserve: a role for psychological factors in ovarian aging? Menopause. 2012 Nov; 19(11):1176-85.
  11. Cakmak H, Fujimoto VY, Zamah AM, Rosen MP, Tran ND, Cedars MI, Rinaudo PF. Metaphase II (MII) oocytes obtained at different time points in the same in vitro fertilization cycle. J Assist Reprod Genet. 2012 Nov; 29(11):1203-5.
  12. Bleil ME, Adler NE, Pasch LA, Sternfeld B, Gregorich SE, Rosen MP, Cedars MI. Psychological stress and reproductive aging among pre-menopausal women. Hum Reprod. 2012 Sep; 27(9):2720-8.
  13. Niemasik EE, Letourneau J, Dohan D, Katz A, Melisko M, Rugo H, Rosen M. Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors. J Cancer Surviv. 2012 Sep; 6(3):324-32.
  14. Schuh-Huerta SM, Johnson NA, Rosen MP, Sternfeld B, Cedars MI, Reijo Pera RA. Genetic markers of ovarian follicle number and menopause in women of multiple ethnicities. Hum Genet. 2012 Nov; 131(11):1709-24.
  15. Letourneau JM, Smith JF, Ebbel EE, Craig A, Katz PP, Cedars MI, Rosen MP. Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer. Cancer. 2012 Sep 15; 118(18):4579-88.
  16. Rosen MP, Meldrum DR. Can FSH co-trigger prevent OHSS? Fertil Steril. 2012 Mar; 97(3):534-5.
  17. Rosen MP, Johnstone E, McCulloch CE, Schuh-Huerta SM, Sternfeld B, Reijo-Pera RA, Cedars MI. A characterization of the relationship of ovarian reserve markers with age. Fertil Steril. 2012 Jan; 97(1):238-43.
  18. Schuh-Huerta SM, Johnson NA, Rosen MP, Sternfeld B, Cedars MI, Reijo Pera RA. Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women. Hum Reprod. 2012 Feb; 27(2):594-608.
  19. Zamah AM, Mauro MJ, Druker BJ, Oktay K, Egorin MJ, Cedars MI, Rosen MP. Will imatinib compromise reproductive capacity? Oncologist. 2011; 16(10):1422-7.
  20. Tran ND, Cedars MI, Rosen MP. The role of anti-müllerian hormone (AMH) in assessing ovarian reserve. J Clin Endocrinol Metab. 2011 Dec; 96(12):3609-14.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.